Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified UBE3A gene for a gene therapy approach for angelman syndrome

Modified UBE3A gene for a gene therapy approach for angelman syndrome

US Patent 11534500 · Granted Dec 27, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Animal model of Angelman Syndrome2023
Drug-induced activation of the Reelin signaling system2023
Drug-induced activation of the Reelin signaling system2022
Recombinant adeno-associated virus-mediated expression of fractalkine for treatm2020
Reelin rescues cognitive function2020
Arginine deiminase gene therapy for disordered proteins2019
Reelin rescues cognitive function2018
Ketone supplements for treatment of angelman syndrome2017
Ketone esters for treatment of angelman syndrome2016
Reelin rescues congnitive function2016
Cubic silicon carbide implantable neural prosthetic2015
I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use2012